Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study - Takeaways - MDSpire

Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study

  • By

  • Sung Hye Kong

  • Ju-young Park

  • Moon-Kyung Shin

  • Hyo-Jung Lee

  • Jin Woo Kim

  • Seung Shin Park

  • Sang Wan Kim

  • Chan Soo Shin

  • Tae-Jin Song

  • December 6, 2024

  • 0 min

Share

  • 1

    Bisphosphonate therapy significantly reduces the risk of major osteoporotic fractures in premenopausal women with a history of fragility fractures.

  • 2

    Ibandronate users experienced notable reductions in both major osteoporotic and nonvertebral fractures compared to nonusers.

  • 3

    Longer duration of bisphosphonate use (≥180 days) is associated with a significantly lower risk of subsequent fractures.

  • 4

    The study utilized a population-based cohort from South Korea, analyzing data from 2003 to 2014 to assess bisphosphonate efficacy.

  • 5

    Findings support considering bisphosphonates as a treatment option for premenopausal women at high risk of fractures.

Original Source(s)

Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study

  • by Sung Hye Kong, Ju-young Park, Moon-Kyung Shin, Hyo-Jung Lee, Jin Woo Kim, Seung Shin Park, Sang Wan Kim, Chan Soo Shin, Tae-Jin Song

  • December 6, 2024

Related Content

Defining orthoplastic limb salvage centers: a systematic review

Link Between Triglyceride Glucose–Body Mass Index and Nonunion Rates in Elderly Patients After Limb Fracture Surgery: A Multicenter Retrospective Analysis

Case Report: Tibial plateau fracture in Charcot neuroarthropathy: a report of two cases with contrasting outcomes